These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 26797344)

  • 1. (123)I-mIBG imaging predicts functional improvement and clinical outcome in patients with heart failure and CRT implantation.
    Curcio A; Cascini GL; De Rosa S; Pasceri E; Veneziano C; Cipullo S; Saccomanno M; Santarpia G; Cuda G; Indolfi C
    Int J Cardiol; 2016 Mar; 207():107-9. PubMed ID: 26797344
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic effect and modulation of cardiac sympathetic function in heart failure patients treated with cardiac resynchronization therapy.
    Moreira RI; Abreu A; Portugal G; Oliveira L; Oliveira M; Rodrigues I; Cruz MC; Cunha PS; Santos V; Clara HS; Carmo MM; Ferreira RC
    J Nucl Cardiol; 2020 Feb; 27(1):283-290. PubMed ID: 29992524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of left ventricular global longitudinal strain with cardiac autonomic denervation as assessed by
    Cruz MC; Abreu A; Portugal G; Santa-Clara H; Cunha PS; Oliveira MM; Santos V; Oliveira L; Rio P; Rodrigues I; Morais LA; Ferreira RC; Carmo MM
    J Nucl Cardiol; 2019 Jun; 26(3):869-879. PubMed ID: 29209951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study.
    Hsu JC; Solomon SD; Bourgoun M; McNitt S; Goldenberg I; Klein H; Moss AJ; Foster E;
    J Am Coll Cardiol; 2012 Jun; 59(25):2366-73. PubMed ID: 22698490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac sympathetic imaging with mIBG in heart failure.
    Carrió I; Cowie MR; Yamazaki J; Udelson J; Camici PG
    JACC Cardiovasc Imaging; 2010 Jan; 3(1):92-100. PubMed ID: 20129538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of low versus high (>40 mm Hg) pulse pressure to predict the benefit of cardiac resynchronization therapy for heart failure (from the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy Trial).
    Sherazi S; Goldenberg I; Moss AJ; Solomon S; Kutyifa V; McNitt S; Shah AH; Huang DT; Aktas MK; Zareba W; Barsheshet A
    Am J Cardiol; 2014 Oct; 114(7):1053-8. PubMed ID: 25118116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrioventricular delay programming and the benefit of cardiac resynchronization therapy in MADIT-CRT.
    Brenyo A; Kutyifa V; Moss AJ; Mathias A; Barsheshet A; Pouleur AC; Knappe D; McNitt S; Polonsky B; Huang DT; Solomon SD; Zareba W; Goldenberg I
    Heart Rhythm; 2013 Aug; 10(8):1136-43. PubMed ID: 23712031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-responders to cardiac resynchronization therapy: Insights from multimodality imaging and electrocardiography. A brief review.
    Carità P; Corrado E; Pontone G; Curnis A; Bontempi L; Novo G; Guglielmo M; Ciaramitaro G; Assennato P; Novo S; Coppola G
    Int J Cardiol; 2016 Dec; 225():402-407. PubMed ID: 27776243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical benefit of cardiac resynchronization therapy for narrow QRS compared to broad QRS complex patients.
    Yap LB; Qadir F; Nguyen ST; Ma SK; Koh KW; Muhammad Z; Arshad AH; Ali Z; Daud A; Tay GS; Sahat NA; Said AA; Tamin SS; Hussin A; Kaur S; Omar R
    Int J Cardiol; 2015 Mar; 183():178-9. PubMed ID: 25666128
    [No Abstract]   [Full Text] [Related]  

  • 10. The QRS narrowing index predicts reverse left ventricular remodeling following cardiac resynchronization therapy.
    Rickard J; Popovic Z; Verhaert D; Sraow D; Baranowski B; Martin DO; Lindsay BD; Varma N; Tchou P; Grimm RA; Wilkoff BL; Chung MK
    Pacing Clin Electrophysiol; 2011 May; 34(5):604-11. PubMed ID: 21276023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interplay between right ventricular function and cardiac resynchronization therapy: an analysis of the CARE-HF trial (Cardiac Resynchronization-Heart Failure).
    Damy T; Ghio S; Rigby AS; Hittinger L; Jacobs S; Leyva F; Delgado JF; Daubert JC; Gras D; Tavazzi L; Cleland JG
    J Am Coll Cardiol; 2013 May; 61(21):2153-60. PubMed ID: 23541971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of ejection fraction on the prognostic value of sympathetic innervation imaging with iodine-123 MIBG in heart failure.
    Shah AM; Bourgoun M; Narula J; Jacobson AF; Solomon SD
    JACC Cardiovasc Imaging; 2012 Nov; 5(11):1139-46. PubMed ID: 23153914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pooled analysis of multicenter cohort studies of (123)I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure.
    Nakata T; Nakajima K; Yamashina S; Yamada T; Momose M; Kasama S; Matsui T; Matsuo S; Travin MI; Jacobson AF
    JACC Cardiovasc Imaging; 2013 Jul; 6(7):772-84. PubMed ID: 23845574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Echocardiographic predictors of reverse remodeling after cardiac resynchronization therapy and subsequent events.
    Park JH; Negishi K; Grimm RA; Popovic Z; Stanton T; Wilkoff BL; Marwick TH
    Circ Cardiovasc Imaging; 2013 Nov; 6(6):864-72. PubMed ID: 24084489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal Influence of Heart Failure Hospitalizations Prior to Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy With Defibrillator on Subsequent Outcome in Mild Heart Failure Patients (from MADIT-CRT).
    Lee AY; Moss AJ; Ruwald MH; Kutyifa V; McNitt S; Polonsky B; Zareba W; Ruwald AC
    Am J Cardiol; 2015 May; 115(10):1423-7. PubMed ID: 25817576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac resynchronization therapy reduces T-wave alternans in patients with heart failure.
    Hua W; Chen K; Zhou X; Dai Y; Chen R; Wang J; Ding L; Liu Z; Feng T; Yu J; Cheng J; Liu C; Zhang S
    Europace; 2015 Feb; 17(2):281-8. PubMed ID: 25398405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A reduction in total isovolumic time with cardiac resynchronisation therapy is a predictor of clinical outcomes.
    Guha K; Mantziari L; Sharma R; McDonagh TA; Gibson D; Duncan AM
    Int J Cardiol; 2013 Sep; 168(1):382-7. PubMed ID: 23041011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
    Linde C; Gold MR; Abraham WT; St John Sutton M; Ghio S; Cerkvenik J; Daubert C;
    Eur Heart J; 2013 Sep; 34(33):2592-9. PubMed ID: 23641006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing cardiac resynchronization therapy in advanced heart failure.
    Mullens W; Tang WH
    Congest Heart Fail; 2011; 17(3):147-51. PubMed ID: 21609389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indexed maximal left atrial volume predicts response to cardiac resynchronization therapy.
    Rossi L; Malagoli A; Piepoli M; Franchi F; Malavasi V; Casali E; Rusticali G; Villani GQ
    Int J Cardiol; 2013 Oct; 168(4):3629-33. PubMed ID: 23725913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.